-
Oritavancin, sold
under the
brand name
Orbactiv among others, is a
semisynthetic glycopeptide antibiotic medication for the
treatment of
serious Gram-positive...
-
Dalbavancin Delafloxacin Fusidic acid
Mupirocin (topical)
Omadacycline Oritavancin Tedizolid Telavancin Tigecycline (also
covers gram negatives) Antibiotics...
-
including aminoglycosides, carbapenems, cephalosporins,
daptomycin and
oritavancin.
Enzymes conferring resistance to
fosfomycin have also been identified...
- have
lipophilic side-chains
linked to glycopeptides. The
class includes oritavancin,
telavancin and dalbavancin. In
September 2009 the US Food and Drug Administration...
-
institutional settings.
Oritavancin was
originally discovered and
developed by Eli Lilly;
Targanta acquired worldwide rights to
oritavancin from
InterMune in...
-
often used as off-label
salvage therapy in
systemic VRE
infections is
oritavancin, a
semisynthetic glycopeptide that has
demonstrated synergic activity...
-
semisynthetic second generation includes lipoglycopeptides like telavancin,
oritavancin and dalbavancin. The
extra lipophilicity not only
enhances Lipid II binding...
-
therapy was used in the past. Tedizolid, telavancin, dalbavancin, and
oritavancin antibiotics are FDA
approved as
treatments against EF.
Endures prolonged...
- and
aliphatic tails. It is part of the
active group in the
antibiotic oritavancin.
Biphenyl prevents the
growth of
molds and fungus, and is
therefore used...
- clobazam, dabrafenib, elagolix, eslicarbazepine, letermovir, lorlatinib,
oritavancin, perampanel, telotristat.
Click on genes,
proteins and
metabolites below...
